Afatinib was obtained from ChemScene LLC (Monmouth Junction, NJ, USA). (S)-N-4-(3-Chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)-quinazoline-4,6-diamine (CTQD) was obtained from Toronto Research Chemicals, Inc. (Toronto, ON, Canada). N-4-(3-Chloro-4-fluorophenyl)-7-methoxyquinazoline-4,6-diamine (CMQD) was obtained from Ark Pharm, Inc. (Libertyville, IL, USA). Vandetanib was obtained from AdooQ BioScience LLC (Irvine, CA, USA). 2,4,6-Trinitrobenzene sulfonic acid was obtained from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Keyhole limpet hemocyanin (KLH) was purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Horseradish peroxidase (HRP) and 3,3′,5,5′-tetramethylbenzidine (TMB) were obtained from Boehringer Ingelheim Pharma GmbH (Ingelheim, Germany). The other reagents and solvents were all of the highest commercially available grade.
Vandetanib
Manufactured by Adooq
Sourced in United States
Vandetanib is a lab equipment product. It is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR).
Automatically generated - may contain errors
Lab products found in correlation
Afatinib, by ChemScene (1 mentions)
2 4 6 trinitrobenzene sulfonic acid, by Tokyo Chemical Industry (1 mentions)
Keyhole limpet hemocyanin klh, by Fujifilm (1 mentions)
Horseradish peroxidase hrp, by Boehringer Ingelheim (1 mentions)
3 3 5 5 tetramethylbenzidine (tmb), by Boehringer Ingelheim (1 mentions)
Trametinib, by Adooq (1 mentions)
Ruxolitinib, by Adooq (1 mentions)
Afatinib, by Adooq (1 mentions)
Dasatinib, by Adooq (1 mentions)
Lenvatinib, by Adooq (1 mentions)
Regorafenib, by LGC (1 mentions)
Gefitinib, by Cayman Chemical (1 mentions)
Elacridar, by LGC (1 mentions)
Ponatinib, by Adooq (1 mentions)
Dabrafenib, by Adooq (1 mentions)
Carfilzomib, by Adooq (1 mentions)
Vemurafenib, by Adooq (1 mentions)
Ko143, by Merck Group (1 mentions)
Dacomitinib, by Adooq (1 mentions)
Lapatinib, by Adooq (1 mentions)
2 protocols using vandetanib
1
Quinazoline-based Inhibitor Synthesis
2
Cell-based Assay of Multi-Targeted Kinase Inhibitors
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Regorafenib, M-2, M-5, and elacridar were purchased from Toronto Research Chemicals (North York, ON). Ko143 was from Sigma-Aldrich (St. Louis, MO). Imatinib mesylate was from Focus Biomolecules (Plymouth Meeting, PA). Afatinib, bortezomib, cabozantinib, carfilzomib, dabrafenib, dacomitinib, dasatinib, lapatinib, lenvatinib, pazopanib, ponatinib, ruxolitinib, tofacitinib, trametinib, vandetanib, and vemurafenib were from AdooQ Bioscience (Irvine, CA). Sorafenib was from LKT Laboratories Inc. (St. Paul, MN). Sunitinib was from Synkinase Pty Ltd. (San Diego, CA). Crizotinib was from LC Laboratories Inc. (Woburn, MA). Gefitinib and erlotinib were from Cayman Chemical Company (Ann Arbor, MI). Nilotinib was from ChemScene, LLC (Monmouth Junction, NJ). All other chemicals and reagents were of analytical grade and were obtained from commercial sources.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!